Table 1.
Clinical characteristics of the subjects included in the study (n = 127)
| Diagnosis | Number of samples |
|---|---|
| Total Breast Cancer | 67 |
| Pure DCIS | 10 |
| Histological grade I | 1 |
| Histological grade II | 2 |
| Histological grade III | 7 |
| Invasive Ductal Carcinoma (IDC) | 49 |
| Histological grade I | 11 |
| Histological grade II | 17 |
| Histological grade III | 16 |
| Histological grade Unknown | 5 |
| Invasive Lobular Carcinoma (ILC) | 4 |
| Histological grade I | 2 |
| Histological grade II | 2 |
| Histological grade III | 0 |
| Other invasive | 4 |
| Invasive Tubular Carcinoma (ITC) | 2 |
| Medullary Carcinoma | 1 |
| Other/mixed cases | 1 |
| Total Non-malignant | 63* |
| Benign changes | 12 |
| Fibroadenoma | 1 |
| Fibroadenoma and haematoma | 1 |
| Cyst | 6 |
| Unspecified findings | 4 |
| No mammographic findings | 42 |
| Controls | 9 |
| Breast feeding | 1 |
| Pregnant | 3 |
| Menstrual cycle (2 subjects) | 5 |
| Total samples | 130* |
* Data from biological replicates were merged leaving 127 assays for analyses.
DCIS = ductal carcinoma in situ